Advisory Services Network’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Advisory Services Network’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-442	Closed	-$31.7K	–	3765
2023 Q4	$31.7K	Buy	+442	New	+$25.4K	﹤0.01%	2269
2023 Q2	–	Sell	-568	Closed	-$30.8K	–	3768
2023 Q1	$30.8K	Hold	568	–	–	﹤0.01%	2282
2022 Q4	$30.1K	Buy	+568	New	+$28.5K	﹤0.01%	2234
2021 Q3	–	Sell	-775	Closed	-$32K	–	3315
2021 Q2	$32K	Buy	+775	New	+$28.6K	﹤0.01%	2242
2021 Q1	–	Sell	-775	Closed	-$25K	–	3023
2020 Q4	$25K	Sell	775 -950	-55%	-$25K	﹤0.01%	2047
2020 Q3	$44K	Buy	+1,725	New	+$39.4K	﹤0.01%	1662

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Advisory Services Network's ITCI Position: Q1 2024 in Review

Advisory Services Network sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2024, closing a stake of 442 shares — an estimated $31.7K sold.

Advisory Services Network first reported a position in ITCI in Q3 2020 and held it in 6 quarters. The position peaked at $44K in Q3 2020. 346 funds tracked by Wall St. Rank hold ITCI as of Q1 2024.

Advisory Services Network reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 442 Intra-Cellular Therapies Inc. shares in Q1 2024, an estimated $31.7K.
Advisory Services Network first reported a position in Intra-Cellular Therapies Inc. in Q3 2020 and held it in 6 quarters.
Advisory Services Network's Intra-Cellular Therapies Inc. position peaked at $44K in Q3 2020.
346 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.